Jonathan Edwards

Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy

Matthew E.R. Butchbach, J. J. Singh, Margrét Þorsteinsdóttir et al. · Human Molecular Genetics · 2009 · 119 citations · Full text

Abnormal motor phenotype in the SMNΔ7 mouse model of spinal muscular atrophy

Matthew E.R. Butchbach, Jonathan Edwards, Arthur H.M. Burghes · Neurobiology of Disease · 2007 · 110 citations · Full text

Abnormal Motor Phenotype, Spinal Cord Injury, Skeletal Muscle +9

Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada

Rick Abbott, Scott Edwards, Maria A. Whelan et al. · Journal of Oncology Pharmacy Practice · 2013 · 64 citations

Outcomes Assessment of a Pharmacist-Directed Seamless Care Program in an Ambulatory Oncology Clinic

Scott Edwards, Rick Abbott, Jonathan Edwards et al. · Journal of Pharmacy Practice · 2013 · 43 citations

Family Medicine, Outcomes Assessment, Primary Care +16

A novel method for oral delivery of drug compounds to the neonatal SMNΔ7 mouse model of spinal muscular atrophy

Matthew E.R. Butchbach, Jonathan Edwards, Kristie R. Schussler et al. · Journal of Neuroscience Methods · 2006 · 38 citations · Full text

Pharmaceutical Science, Spinal Cord Injury, Pharmacological Study +9